Full Text View
Tabular View
No Study Results Posted
Related Studies
Sitagliptin in the Elderly
This study is currently recruiting participants.
Verified February 2012 by University of British Columbia
Study NCT00451113   Information provided by University of British Columbia

First Received on March 21, 2007.   Last Updated on February 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Sitagliptin 100 mg
Additional drug interventions recognized in this trial
Dipeptidyl-Peptidase IV Inhibitors
Sitagliptin
More general drug interventions related to this trial
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Sponsors listed in this trial
University of British Columbia
Merck Frosst Canada Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services